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Abstract Two human leukemia cells K562 and THP-1, the
breast cancer lines MCF-7 and ZR-75-1, and the melanoma
line MDA-MB-435S were compared by flowcytometry for
their behaviour at increasing levels of 3BP. K562 and THP-1
responded to 3BP by membrane depolarization and increased
ROS; MCF-7 and ZR-75-1 showed decreased polarization and
low ROS increase;MDA-MB-435S had limited depolarization
and no ROS increase. THP-1 cells exposed to a range of 3BP
concentrations in combination with DCA showed increase of
polarization, slight ROS increase, and weakened nuclear
integrity. 3BP and DCA show no synergism, but have
complementary destructive effects on THP-1 cells. The data
led to the conclusion that the THP-1 cells do not carry a
functional membrane monocarboxylate transporter (MCT) or
that 3BP circumvents MCT binding and can enter these cells
independently.
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Introduction
The past 30 years have seen a dramatic increase in the
number of drugs for the treatment of cancer. This develop-
ment has been spurred by the rapid developments in the area
of molecular biology, biochemistry and chemical synthesis,
resulting in ever more complex drugs that can be tested for
their biological efficacy. The growing insight in (sub) cellu-
lar communication pathways, involving complex regulation
cascades has provided an overwhelming number of drugs
intended to disrupt the cellular processes that allow tumors
to thrive and destroy their host. Unfortunately, cancer cells
have the ability to evade the very specific action of many of
these new drugs, either by circumventing their accumulation
in their cells by a series of transporters, aimed at eliminating
these drugs from the cells interior, or by escaping their
action by mutations on the active sites of the enzymes which
are the target of these drugs. In combination with severe
deleterious effects of most of these drugs on the essential
processes for the patient, this results in a heavy burden to the
patients who undergo these treatments. In order to extend
the range of useful drugs, new insights are needed.
85 years ago, a common feature of the cells comprising
solid tumors was discovered by Warburg: aerobic glycolysis
(Warburg et al. 1926). In contrast to normal glycolysis, this
process is able to run under aerobic conditions, and provides
the tumor cells with a set of unique properties. The first step in
this process is catalyzed by the enzyme hexokinase, and most
solid tumors have isoform 2 overexpressed. This enzyme is
the basis for the application of 18 F-deoxyglucose as a tracer
for the localization of malignant cells in a PET-scan. This
sugar analog is taken up by all cells, but only hexokinase 2
(HK2) is able to phosphorylate it into a form which cannot be
metabolized further due to the deoxy character of this sugar,
resulting in accumulation in malignant cells, thereby enabling
the localisation of these cells by looking for the annihilation
radiation of the emitted positron. The relatively low energy of
the positron improves localization resolution.
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Hexokinase 2 is bound to the voltage dependent anion
channel (VDAC) complex of the mitochondria, thus causing
hyperpolarization and inhibiting apoptosis and cell death
(Chen et al. 2009).
3-Bromopyruvate (3BP) has been shown to eradicate
liver tumors in an animal test system (Ko et al. 2004;
Geschwind et al. 2002) and it has been shown to inhibit
HK2 by binding covalently in the active site of the enzyme
by alkylation of a cysteine residue (Porporato et al. 2011). In
addition, it inhibits a number of other enzymes from the
glycolytic pathway, such as glyceraldehyde-3-phosphate
dehydrogenase, and succinate driven ATP synthesis
(Dell’Antone 2009).
Dichloroacetate (DCA) is a pyruvate dehydrogenase
kinase inhibitor which leads to increased pyruvate dehy-
drogenase activity (Papandreou et al. 2011). This causes
in cells increased conversion of pyruvate to acetyl-CoA
rather than lactic acid, and stimulates mitochondrial res-
piration by increasing the supply of acetyl-CoA. Al-
though DCA is not a specific inhibitor of tumor cell
glycolysis (Stockwin et al. 2010), it may be used to
target cells that show defects in the mitochondrial elec-
tron transport chain. DCA could have a synergistic ac-
tivity with anti-cancer drugs that impair mitochondrial
activity. It has been used to inhibit growth of tumor cells in
vitro (Sun et al. 2010) as well as in vivo (Michelakis et al.
2010). To study the effects of 3BP and DCA individually as
well as combined on tumor cell growth in vitro we used 2
different leukemia derived cell lines, i.e. the monocytic leuke-
mia line THP-1 (Tsuchiya et al. 1980) and the erythroleuke-
mia line K562 (Lozzio and Lozzio 1975), and 3 cell lines
derived of solid tumors, the breast tumor lines MCF-7 (Soule
et al. 1973), ZR-75-1 (Engel et al. 1978) and the melanoma
line MDA-MB-435S (Ellison et al. 2002).
In this paper we present data on the comparison of the
effects of 3BP on various tumor derived human cell lines,
along with data from combined treatments of the THP-1
monocyte derived cell line. The mechanisms involved in the
activation of ROS species and membrane depolarization are
discussed, with emphasis on the presumed role of membrane




Cells were obtained from the following sources. THP1
cells were obtained from Cell Lines Service, Eppel-
heim, Germany; K562 were kindly provided by Prof.
H.F.J. Savelkoul, Dept. Cell biology and Immunology,
Wageningen UR; the other cell lines were provided by
Dr. Young Ko, Johns Hopkins University, School of Medi-
cine, Baltimore, USA. All cells were grown in RPMI 1640
culture medium (Sigma, cat R8758) supplemented with 10%
heat-treated newborn calf serum (Gibco, cat. 161010-159) and
penicillin/streptomycin (Sigma-Aldrich) at 37 °C in a humid-
ified incubator at 5% CO2.
3BP, dihydroethidium, propidium iodide and other chem-
icals were obtained from Sigma-Aldrich, except JC1, which
was obtained from Enzo Life Sciences (cat. Enz-52304),
Cell culture
THP-1 and K562 cells were plated in 24 well plates
(Costar) with cell density of 2×105 cells resp. 4×105
cells per well . The adherent cell lines were plated 4 days
before the experiment and used when 80% confluent.
After 24 h cultures of THP-1 and K562 were used
directly for staining and flowcytometry purposes. The
adherent cultures were first trypsinized and cells were
washed in complete medium and collected by centrifuga-
tion. For 3BP and DCA treatment respectively a solution
of 10 mM 3BP was freshly made in PBS and sterilized
by ultrafiltration, while 1 M DCA was prepared in water,
brought to pH 7 with NaOH, sterilized by ultrafiltration
and if necessary stored frozen.
JC-1 staining
JC-1 staining for determining mitochondrial membrane po-
larization was carried out by adding 4 μg/ml JC-1 to the
medium after which the cells were directly used for
flowcytometry.
Dihydroethidium (DHE) staining
DHE staining for determining the amount of reactive oxy-
gen species was carried out by adding 100 ng/ml DHE to the
medium after which the cells were directly used for
flowcytometry.
Propidium iodide (PI) staining
Cells were collected by centrifugation and suspended in
PBS. RNA was degraded by adding 20 μg/ml RNase A
(DNase-free) and incubating for 1 h at room temperature.
Cells were then stained by adding 1 volume of 0.1% Triton
X100 in PBS and 10 μg PI per ml. Cells were then imme-
diately used for flowcytometry.
Effect of N-Acetylcysteine
Cells were incubated at 37 °C with 0, 10, 20, and 50 μM N-
Acetylcysteine (NAC) in a 24 well plate in a matrix setting
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with 0, 10, 20, and 50 μM 3BP and harvested after 24 h.
NAC treatment was started 1 h. before the addition of 3BP
in order to saturate cells with NAC.
Flow cytometry
A DAKO Cyan instrument was used for flowcytometric anal-
ysis, equipped with a 488 solid state blue green laser, operated
at 10 mWoutput power. The standard filter/dichroic mirror set
was used, and 4 fluorescence, forward scatter and sideward
scatter signals were recorded, in both logarithmic and linear
mode.
Data were collected from the samples during a run of 30 s
per sample. In this way, about 1,500 to 6,000 cells were
analyzed during every run, allowing a comparison of cell
growth or toxic effects of the treatments. Experiments were
performed in duplo, with one replicate stained with JC1 and
the other with DHE. In one experiment also DNA amount
was determined by PI staining. Gating was applied in the
forward/sideward scatter diagram to select for intact cells.
Data analysis
Data were recorded in fcs3 file format and analysed using the
free version of Cyflogic, version 1.2.1 (www.cyflogic.com).
Selected data were exported to Excel for statistical analysis,
using the StatistiXL version 1.8 (www.statistiXl.com) plug in.
The casewise PCA scores were plotted as round dots in graphs
with the relevant PC’s on the horizontal and vertical axis.
Component Score Coefficients (Eigenvectors) were indicated
in these graphs with small squares as endpoint.
Results
Cell line comparison
In total, 5 different human cell lines were tested for their
behaviour at increasing levels of 3BP. For this purpose, the
following parameters were extracted from the flowcytometry
data files: Median intensity of fluorescence intensity of JC1
resp. DHE staining, together with the CVof the distribution,
median of the forward and sideward scatter signal, andmedian
and gated signal of the pulse time, in order to discriminate
between single cells and clusters.
The PCA plot (all parameters normalized to 1SD) of
these data (from one experiment) is represented in Fig. 1.
From this diagram can be concluded that all cell lines show
clear differences in the parameters extracted from the data.
The horizontal axis (PC1, 45.8% of variance) differentiates
between the strongly adherent cells on the left (MCF-7 and
ZR-75-1), which show a large amount of clustering (35 to
50% doublets), indicated by the higher pulse time (vector
PTmean_jc1), when compared to the single cells of THP-1,
K562 and MDA-MB-435S cells (5 to 10% doublets). The
arrows within the ellipses indicate the direction of the effects
of increasing 3BP concentrations, with the arrowhead rep-
resenting 500 μM 3BP. The inversion point, marked with a
diamond, indicates the highest concentration of 3BP that
does not result in massive cell death (50 μM for THP-1, and
ZR-75-1, 100 μM for MCF-7, and no limit for K562).
These diagrams also reveal strong differences in the cellu-
lar response to increasing 3BP concentrations. The K562 and
THP-1 lines respond both by membrane depolarization and
Fig. 1 PCA plot of the
comparison of the response to
increasing concentrations of
3BP of 5 different cell lines.
Concentrations are indicated at
each round dot, representing
one experiment. The lines
ending with squares are the
eigenvectors of the individual
measured parameters,
quantified from the
flowcytometry data. For clarity,
only selected parameters were
labelled. The arrows indicate
the increasing 3BP
concentrations (0, 10, 20, 50,
100 and 500 μM), with the
arrowhead at 500 μM. The
inversion point (diamond)
indicates the highest tolerated
3BP concentration, marked in
all cases, except K562
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increased ROS production, as shown by their orientation
parallel to the vectors representing the Fl_jc1 and Fl_dhe
signals for JC1 and DHE respectively. The ZR-75-1 and
MCF-7 do respond with a decrease of their membrane poten-
tial, but ROS production is much less pronounced than with
THP-1 and K562. The same holds true for MDA-MB-435S,
which did not respond with any ROS production increase and
very limited membrane depolarization. The MDA-MB-435S
line shows its strongest response in the forward scatter signal
(vector FS_dhe), indicating that cells respond by increasing
size with increasing 3BP concentrations. This is also true, but
to a lesser degree with MCF-7 and ZR-75-1.
These aspects are illustrated in Fig. 2, which shows a
selection of the most discriminant features detected in the
flowcytometry data. Each cell line has a distinct pattern in
the combined forward/sideward scatter plot (left column).
The gating of the cells for detection of the fluorescence profiles
is accommodated accordingly to the different scatter properties
of each cell line. The pulse time histograms reveal the exces-
sive clustering (50%) of cells in theMCF-7 and less in the ZR-
75-1 cell lines (35%) (indicated by the solid arrows). The JC1
and DHE fluorescence distributions presented are from the
0BP (solid line) and that concentration of 3BP which gave
the first change of membrane potential, the concentration being
marked to the left of the diagrams. The MCF-7 cells did react
with membrane depolarization at 100 μM 3BP, but did not
show any increase of ROS at this concentration. At 200 μM,
the MDA-MB-435S exhibited the first signs of membrane
depolarization and a shift to higher ROS production. The
ZR-75-1 cells did react to 50 μM 3BP but showed a drastic
effect at 100 μM as shown in Fig. 2. THP-1 has a consistent
effect in all our experiments which starts at 20 μM and results
in massive cell damage at 50 μM. No effect could be noted on
K562 cells until the concentration reached 500 μM. At this
concentration, the resistance of this cell line to 3BP collapses
dramatically, with rapid membrane depolarisation and ROS
increase.
Effects of combined 3BP and DCA treatments on THP-1 cells
Cells were incubated in 24 well plates for 24 h at different
concentrations of 3BP and DCA and a combination of both
i.e. 0, 10, 20, 50 μM 3BP and 0, 2, 5, 10, 20, 50 mM DCA.
Although the highest concentration of both compounds
caused obvious cell death of THP-1 cells as determined by
strongly increased trypan blue uptake in the nuclei (data not
shown), no prevalence of apoptosis was observed in PI
stained cell preparations (data not shown).
The effects of the various combinations of 3BP and DCA
are summarized in Fig. 3. This PCA plot (with data from
one experiment) shows the control in the upper right hand
corner (marked 0BP) and increasing concentrations of DCA
(2, 5, 10, 20 and 50 mM) are connected with solid lines,
with 50 mM at the arrowhead. The dashed lines are con-
necting points with identical concentrations of the increas-
ing 3BP concentrations at the various DCA concentrations,
with the arrowhead indicating 50 μM 3BP.
The effect of DCA is mainly an increase of membrane
depolarization, while only slightly increasing ROS activity.
In addition, increasing DCA concentrations have a strong
effect on both the median and the CV of the PI signal
(vectors Fl_pi and CV_pi respectively), suggesting an effect
on nuclear integrity. To a lesser degree an effect is visible on
the sideward scatter signals (vectors SS_dhe and SS_jc1),
which would support this observation. Increasing 3BP con-
centrations finally leads to a strong reduction of membrane
potential and strong induction of ROS activity, indicated by
the cluster with all 50 μM 3BP treatments in the left part of
the diagram (dotted ellipse).
The data from all combination experiments with
DCA, and two combinations with the addition of lac-
tate, are summarized in Fig. 4. Since variation occurs in
between experiments in the intensity of the JC1 and
DHE staining, caused by fluctuations in cell viability
between batches of cells, a different approach was taken
for the processing of these results. The median of the
JC1 and DHE fluorescence distributions of sample of 0
BP without additions was chosen as reference, and all
other median fluorescence values were expressed as the
ratio of the sample with the reference. All relative
values were then averaged over the different experi-
ments. Due to the number of samples that could be
processed in a limited time, not all experiments did
encompass all combinations tested. The points with
0BP are indicated with open symbols, and each line is
labelled with the concentration of DCA or lactate (LAC)
used.
This figure shows the strong induction of ROS ac-
tivity (about 10 times), along with membrane depolar-
ization due to 3BP alone (2 times), or in combination
with DCA and lactate. The effect of DCA is most
clearly on the membrane depolarization, with a slight
reduction (halving) in ROS stimulation by 3BP, which
is most apparent in the 5 mM DCA samples. The
graphs from the 10 and 20 mM DCA treatments show
similar effects on membrane depolarisation and ROS
induction, indicating a saturation effect when compared
to 2 and 5 mM DCA.
The 50 mM DCA samples show a reduced membrane
depolarisation which is caused by the damaged mem-
branes of the cells and a strong reduction in cell numb-
ers (data not shown). The slope of the lines connecting
the 0 3BP treatments and the 50 μM 3BP treatments for
0 to 5 mM DCA are virtually parallel, indicating a lack
of synergy of these two treatments, but rather pointing
towards complementary effects. Higher concentrations of
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Fig. 2 Typical details from the flowcytometric data of each cell line.
Details were selected according to the PCA plot to show the most
discriminant features at the concentration of 3BP which inflicted the
most effects on each cell line. The scatterplots show the combined
forward (horizontal axis) and sideward (vertical axis) scatter, along
with the area used for gating. The pulse time histogram(horizontal axis)
of the gated cells is shown to indicate the presence of clusters in the
MCF-7 and ZR-75-1 cell lines (solid arrows), together with the quan-
tification windows histo-2 and histo-3. For both JC1 and DHE fluo-
rescence intensity histograms (fluorescence intensity on the horizontal
axis), the zero BP (solid line), as the 3BP concentration (indicated at
the left following the / as μM) at which the most drastic changes were
identified are given as grey shaded area
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DCA show an increase in ROS activity but without
increase of membrane polarization.
The combinations with lactate show a reduced (about
60% reduction) increase of ROS activity by increasing
3BP concentration which is comparable to the effect of the
5 mM DCA combination. The effect of increasing 3BP
concentrations in combination with lactate leads to an even
stronger membrane depolarization than when compared to
DCA or 3BP alone.
Effects of combined treatments with 3BP and NAC
The results of this experiment are shown in the PCA plot in
Fig. 5. This figure reveals a complicated interaction between
3BP and NAC. At lower concentrations of 3BP (up to
20 μM), NAC is able to compensate the membrane depo-
larization induced by 3BP at 10 and 20 μM NAC. Higher
concentrations of NAC (50 and 100 μM) have their own
effect on cellular parameters, the most obvious one being
Forward scatter (vector FS_dhe), indicating an increase of
cell size. Only 50 μM 3BP (BP50) induces a strong increase
of ROS (3X, vector Fl_dhe) and increasing concentrations
of NAC (NAC10, NAC20 and NAC50) strongly affect the
ROS induction in a dose dependent way, resulting in a
strong reduction at 50 μM.
Discussion
It remains a mystery why the glycolytic nature of the energy
supply of solid tumors has escaped research efforts for so
long. In this paper we present data about the effect of 3BP,
assumed to be an inhibitor of HK2, the first dedicated
enzymatic step in aerobic glycolysis of tumor cells (Ko et
al. 2001; Pedersen 2007) on different human cell lines,
derived from solid tumors, (MCF-7, ZR-75-1, MDA-MB-
435S) and the suspension culture lines, THP-1 and K562,
Fig. 3 PCA plot of selected
parameters from the cells,
analysed using JC1, DHE and
PI in combination with RNase
treatment. The eigenvectors of
the individual parameters are
represented by the lines and
marked by the name of the
parameter. For clarity only
selected parameters were
labelled. Control cells are
located in the upper right corner
of the plot (at the dot labelled
BP0, whereas the 50 μM 3BP
treated samples are in the left of
the diagram within the dotted
ellipse. Corresponding
treatments are connected via
arrows (3BP ranges) or dotted
arrows (DCA ranges), with the
arrowhead marking the highest
3BP (50 μM) and DCA
(50 mM)
Fig. 4 Double logarithmic representation of the average ratios of
median values of JC1 and DHE fluorescence of combinations of 3BP
(0, 10, 20 and 50 μM) with DCA (0, 2, 5, 10, 20 and 50 mM) and
lactate (LAC) (2 and 5 mM) (Pooled from 7 independent experiments).
The 0 BP (Marked with an open symbol) samples are indicated. The
arrows represent the trend of the 50 μM 3BP treatment. The zero BP
sample was taken as reference, therefore its location at coordinate (1,
1). The units along the axis indicate fold increase or decrease due to
increasing 3BP concentrations in combinations with DCA and lactate.
Number of experiments: DCA 0 mM: 7; DCA 2 mM: 3; DCA 5 mM:
6; DCA10mM: 6; DCA 20 mM: 5; DCA 50 mM: 2; lactate 2 mM: 2
and lactate 5 mM: 2
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that both have a myeloid leukemia origin. Here we further
give a detailed analysis of various aspects of the THP-1 cells
under different combined regimes of 3BP with DCA, lactate
and N-acetyl cysteine.
The flowcytometry data (Fig. 1) show a quite distinct
reaction of the various cell lines on exposure to 3BP,
depending on the characteristics of the particular cell line.
They all share the phenomenon of membrane depolarisation
with increasing 3BP concentrations, whereas the main dif-
ference between these cells lines appears to be the induction
of ROS production with increasing 3BP concentration. This
latter property seems to be linked to the leukemia derived
lines THP-1 and K562, with virtually no activity in the solid
tumor derived lines MCF-7, ZR-75-1 and MDA-MB-435S.
Monocytes such as THP-1 cells are able to differentiate
into macrophages, which have a functional ROS system in
place to kill pathogens and clean up cellular debris by
phagocytic activity (Mosser and Edwards 2008), and THP-
1 can be induced into macrophages by treatment with PMA
(Tsuchija et al. 1982). K562 will differentiate into the ery-
throid direction when treated with hemin, upon which
(TNF)-related apoptosis-inducing ligand (TRAIL) binding
suffices to direct the cells to apoptosis (Hietakangas et al.
2003). Tumor cells, and especially those of solid tumors, do
not have an active ROS system in place due to the hyper-
polarization caused by HK2, which can be up-regulated 500
fold in liver tumor cells (Chen et al. 2009; Arora and
Pedersen 1988). They merely rely on the aerobic glycolysis
for their energy production (Pedersen 2007; Mosser and
Edwards 2008). The key component of this process is as-
sumed to be HK2, which is expressed in all malignant
tumors, and to some degree, in healthy kidney cells (Kamel
and Schwarzfischer 1975).
This is consistent with the observation that in any PET
scan, the kidneys always show up as positive, regardless
of their being a tumor in the kidneys (Chang et al. 2006).
It would be a challenge to synthesize 76Br (Ribeiro et al.
1999) labelled 3-bromopyruvate and perform a PET scan
with it, to find whether it will co-locate with the signal of
18 F deoxyglucose, as used in conventional PET scanning.
The levels of 3BP needed to cause membrane depolarisa-
tion and/or ROS induction differ for the lines tested in these
experiments. K562 is the most resistant, showing no effects
at all concentrations tested until complete collapse at
500 μM, whereas ZR-75-1, MDA-MB-435S and THP-1
already show signs of 3BP effects at 50 μM. MCF-7 was
found to react at 100 μM, which is in good agreement with
results in another laboratory (Fatima Balthazar, personal
communication).
If the membrane depolarisation is the key action of 3BP,
then it should be inducible even under circumstances where
ROS activation is inhibited. This appears to be the case, as is
clear from the data on the flowcytometry details (Fig. 2) and
the combined NAC-3BP treatments (Fig. 5). It is well
Fig. 5 PCA plot of a combination experiment of varying 3BP (0, 10,
20 and 50 μM ) concentrations with varying NAC concentrations (0,
10, 20, 50 and 100 μM). NAC incubation was started 1 h before
addition of 3BP in order to saturate the cells with NAC. Control cells
are represented by the dot marked 0BP. Two solid arrows indicate 0BP
and 50BP ranges. The dotted lines connect dots of cells with the same
NAC concentration, indicated on the 50BP arrow. Eigenvectors are
indicated and marked where appropriate
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known that NAC is able to counter the effects of 3BP (Kim
et al. 2008). This is also obvious from our data, but what
remains is the reduction of the membrane potential, regard-
less of the concentration of NAC used, provided it is above
the threshold level, as is shown by Fig. 5.
The combination of 3BP with DCA and lactate has revealed
that no concentration of DCA or lactate can abolish the ROS
induction and membrane depolarisation by 3BP. This looks
trivial, but recent research has suggested that membrane mono-
carboxylate transporters (MCT’s) (Halestrap and Price 1999)
are responsible for the accumulation of 3BP in tumor
cells (Thangaraju et al. 2009), contrasting the mecha-
nism by covalent binding to a cysteine in the active site
of HK2, as shown by Pedersen (Pedersen 2007). The Km of
this transporter isolated from rat liver cells and Ehrlich Lettre
tumor cells frommouse shows an affinity for lactate and DCA
of resp. 4.5 and 0.6 mM (Jackson and Halestrap 1996).
It seems remarkable that 3BP has such a profound effect
on THP1 cells in the presence of 100- 1,000 fold excess of
DCA. Assuming that the excess of DCA completely satu-
rates the monocarboxylate transporter MCT-1, 3BP cannot
be transported into the cell and hence would show no effect.
Figure 3 shows the effects of 3BP and DCA alone and in
combination. This may lead to the conclusion that the cells
do not carry MCT-1 or that 3BP circumvents MCT-1 bind-
ing and can enter independently of MCT-1.
Figure 4 also shows that the effect of 3BP on ROS
production is almost constant, except for the DCA 5 mM
and both lactate co-treatments. In these cases, ROS stimu-
lation was halved compared to all other treatments. The
trends for zero BP (up to 5 mM DCA) and 50 BP combined
treatments were almost identical showing that the effects of
the combination are additive, not synergistic. This implies
that 3BP and DCA are working along different mechanisms,
and that they could be combined safely, without any inter-
fering complexities.
The NAC data show that some aspects of 3BP can be
countered by the glutathione based defense system, as has been
demonstrated with melanoma cell lines (Qin and Nickoloff
2010; Mannervik et al. 1987) and which is demonstrated in
these experiments by the K562 cell line. This line has been
demonstrated to be a glutathione S-transferase overexpressor
(Yang et al. 2001), which makes it resistant to oxidative stress.
K562 was the only cell line which did not give in to increasing
3BP concentration with regard to membrane depolarisation and
ROS activity until 500 μMwas reached (Figs. 1 and 2). This is
consistent with the observations in an experiment using mela-
noma cell lines which exhibited extreme resistance to 3BP
treatment, until they are treated with L-buthionine, S,R,-sulfox-
imine. After pre-treatment with this compound at 1 mM during
24 h, all resistant cells were depleted in their glutathione levels
and efficiently killed by subsequent 200 μM 3BP treatment
(Qin and Nickoloff 2010). This shows the power of the
combination of inhibitors with different targets in the treatment
of resistant tumors.
Our results show that the combination of THP-1 and K562
may serve as a useful model system to study the combination of
3BP and DCA on one hand, and possible resistance mecha-
nisms due to glutathione on the other hand. The effects of DCA
and 3BP on THP-1 show that they are additive and not inter-
fering with each other provided the concentrations used do not
exert cytotoxic effects to healthy cells.
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